Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.31 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 41.37.
Market Cap
8.31T
Revenue
4.52T
Profits
200.88B
PE Ratio
41.37
Profit Margin
4.44%
Dividend Yield
0.42%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 808.04B | -1.83% | 4,062,419 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 544.73B | -1.96% | 11,679,819 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 362.81B | 0.69% | 7,771,170 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 314.06B | 6.96% | 26,394,604 | 447.57B |
| 5 | AZN | AstraZeneca PLC | 305.04B | -2.45% | 2,130,102 | 58.74B |
| 6 | NVS | Novartis AG | 283.90B | -2.00% | 2,117,487 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 278.01B | -3.88% | 12,766,661 | 65.01B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 194.94B | -0.28% | 2,140,693 | 44.56B |
| 9 | AMGN | Amgen Inc. | 186.12B | -1.51% | 2,065,932 | 36.75B |
| 10 | NVO | Novo Nordisk A/S | 172.32B | -2.57% | 25,183,787 | 48.59B |
| 11 | GILD | Gilead Sciences, Inc. | 165.44B | -1.90% | 6,069,347 | 29.44B |
| 12 | ABT | Abbott Laboratories | 161.49B | -3.42% | 17,160,404 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 160.28B | -3.07% | 3,378,456 | 10.58B |
| 14 | PFE | Pfizer Inc. | 155.35B | -0.76% | 29,828,829 | 62.58B |
| 15 | DHR | Danaher Corporation | 137.69B | -0.49% | 7,861,811 | 24.78B |
| 16 | SYK | Stryker Corporation | 125.35B | -3.26% | 1,690,241 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.26B | 0.44% | 8,999,355 | 48.19B |
| 18 | SNY | Sanofi | 114.99B | -1.79% | 2,546,281 | 54.85B |
| 19 | GSK | GSK plc | 112.32B | -2.14% | 3,998,255 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 111.05B | -0.59% | 986,799 | 12.00B |
| 21 | HCA | HCA Healthcare, Inc. | 105.34B | -1.45% | 992,905 | 75.60B |
| 22 | MDT | Medtronic plc | 105.28B | -3.53% | 10,784,954 | 35.48B |
| 23 | MCK | McKesson Corporation | 103.17B | -1.95% | 1,240,977 | 397.96B |
| 24 | CVS | CVS Health Corporation | 99.14B | 1.02% | 7,440,535 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 88.46B | -2.41% | 26,839,890 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.69B | -0.27% | 706,496 | 14.34B |
| 27 | CI | The Cigna Group | 72.95B | -1.15% | 1,974,946 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 72.07B | 2.74% | 2,101,405 | 199.13B |
| 29 | MDLN | Medline Inc. | 62.41B | -1.55% | 6,345,596 | 28.43B |
| 30 | COR | Cencora, Inc. | 60.77B | -3.29% | 1,966,455 | 325.78B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 54.39B | -2.79% | 3,681,017 | 28.48B |
| 32 | ARGX | argenx SE | 50.17B | -3.48% | 270,414 | 4.24B |
| 33 | ZTS | Zoetis Inc. | 49.70B | -3.70% | 3,727,943 | 9.47B |
| 34 | CAH | Cardinal Health, Inc. | 48.22B | -2.96% | 1,562,120 | 244.67B |
| 35 | EW | Edwards Lifesciences Corporation | 45.96B | -2.12% | 4,880,694 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.19B | -2.41% | 577,840 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.62B | -1.23% | 3,213,531 | 21.92B |
| 38 | HLN | Haleon plc | 42.39B | -1.55% | 7,573,034 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.90B | -0.81% | 1,510,825 | 3.71B |
| 40 | ALC | Alcon Inc. | 38.63B | -3.09% | 2,076,821 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.43B | -2.28% | 3,725,960 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.63B | -1.81% | 190,568 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 34.50B | 0.93% | 1,799,417 | 7.07B |
| 44 | GEHC | GE HealthCare Technologies Inc. | 32.97B | -2.55% | 2,719,391 | 20.63B |
| 45 | WAT | Waters Corporation | 32.91B | -0.11% | 999,221 | 3.17B |
| 46 | RMD | ResMed Inc. | 32.09B | -2.18% | 1,127,670 | 5.40B |
| 47 | RVMD | Revolution Medicines, Inc. | 31.32B | 1.83% | 2,827,834 | - |
| 48 | INSM | Insmed Incorporated | 30.43B | -1.29% | 1,591,163 | 606.42M |
| 49 | IQV | IQVIA Holdings Inc. | 29.49B | -0.61% | 1,831,360 | 16.31B |
| 50 | RPRX | Royalty Pharma plc | 29.33B | 0.37% | 4,270,897 | 2.38B |
| 51 | NTRA | Natera, Inc. | 29.11B | -1.12% | 769,847 | 2.31B |
| 52 | BNTX | BioNTech SE | 28.22B | 6.09% | 2,753,464 | 3.37B |
| 53 | VEEV | Veeva Systems Inc. | 27.41B | -0.62% | 1,792,413 | 3.20B |
| 54 | BIIB | Biogen Inc. | 27.29B | 1.42% | 1,063,088 | 9.89B |
| 55 | PHG | Koninklijke Philips N.V. | 27.28B | -2.43% | 1,120,571 | 20.94B |
| 56 | MTD | Mettler-Toledo International Inc. | 26.81B | -0.03% | 151,313 | 4.03B |
| 57 | HUM | Humana Inc. | 26.10B | 3.34% | 3,066,838 | 129.66B |
| 58 | UTHR | United Therapeutics Corporation | 25.13B | - | 350,380 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 24.16B | -3.13% | 4,354,631 | 4.66B |
| 60 | DGX | Quest Diagnostics Incorporated | 22.69B | 4.45% | 2,426,121 | 11.28B |
| 61 | LH | Labcorp Holdings Inc. | 22.47B | 1.57% | 674,934 | 13.95B |
| 62 | STE | STERIS plc | 21.52B | -3.07% | 1,203,862 | 5.83B |
| 63 | MRNA | Moderna, Inc. | 21.51B | -0.66% | 6,195,339 | 1.94B |
| 64 | ROIV | Roivant Sciences Ltd. | 20.96B | 0.72% | 2,946,101 | 13.31M |
| 65 | SMMT | Summit Therapeutics Inc. | 20.45B | 5.02% | 10,196,611 | - |
| 66 | ILMN | Illumina, Inc. | 20.05B | -0.66% | 1,547,218 | 4.34B |
| 67 | WST | West Pharmaceutical Services, Inc. | 19.79B | -1.18% | 947,744 | 3.07B |
| 68 | CNC | Centene Corporation | 19.25B | 2.17% | 3,656,399 | 176.15B |
| 69 | INCY | Incyte Corporation | 19.15B | -0.72% | 1,478,414 | 5.14B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 17.94B | -2.92% | 1,841,583 | 8.23B |
| 71 | VTRS | Viatris Inc. | 17.15B | -0.94% | 11,973,054 | 14.30B |
| 72 | GMAB | Genmab A/S | 16.71B | -3.05% | 3,779,304 | 3.72B |
| 73 | THC | Tenet Healthcare Corporation | 16.13B | -3.03% | 2,093,465 | 21.31B |
| 74 | ASND | Ascendis Pharma A/S | 14.85B | -2.07% | 558,221 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.77B | -0.65% | 1,466,882 | 502.08M |
| 76 | MEDP | Medpace Holdings, Inc. | 14.70B | -2.56% | 366,346 | 2.53B |
| 77 | SNN | Smith & Nephew plc | 14.08B | -4.00% | 1,612,922 | 6.16B |
| 78 | RGC | Regencell Bioscience Holdings Limited | 14.04B | 1.07% | 121,419 | - |
| 79 | ALGN | Align Technology, Inc. | 13.98B | 1.85% | 1,466,901 | 4.03B |
| 80 | PODD | Insulet Corporation | 13.32B | -4.25% | 788,650 | 2.71B |
| 81 | COO | The Cooper Companies, Inc. | 13.13B | -3.11% | 1,683,344 | 4.15B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.10B | -1.04% | 932,907 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.86B | -0.82% | 1,085,298 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.69B | -3.09% | 1,327,069 | 2.94B |
| 85 | FMS | Fresenius Medical Care AG | 12.56B | -0.99% | 413,625 | 23.05B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -0.12% | 1,818,668 | 943.71M |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 12.25B | -1.74% | 990,797 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.11B | 0.11% | 209,211 | 958.40M |
| 89 | SOLV | Solventum Corporation | 11.96B | -1.53% | 778,912 | 8.33B |
| 90 | GH | Guardant Health, Inc. | 11.85B | -0.78% | 2,470,808 | 982.02M |
| 91 | EXEL | Exelixis, Inc. | 11.66B | 5.23% | 3,497,944 | 2.32B |
| 92 | ELAN | Elanco Animal Health Incorporated | 11.29B | -4.52% | 4,863,799 | 4.72B |
| 93 | ENSG | The Ensign Group, Inc. | 11.20B | -2.94% | 799,935 | 5.06B |
| 94 | UHS | Universal Health Services, Inc. | 10.90B | -0.65% | 535,634 | 17.36B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 10.86B | -2.44% | 2,661,903 | 3.85B |
| 96 | RVTY | Revvity, Inc. | 10.54B | 1.33% | 1,089,806 | 2.86B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.50B | -0.47% | 1,502,055 | 3.22B |
| 98 | EHC | Encompass Health Corporation | 10.22B | -3.29% | 790,179 | 5.94B |
| 99 | DVA | DaVita Inc. | 10.01B | 0.38% | 461,782 | 13.64B |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.95B | 2.60% | 2,208,003 | 1.09B |
| 101 | TEM | Tempus AI, Inc. | 9.88B | -2.87% | 5,477,962 | 1.27B |
| 102 | BAX | Baxter International Inc. | 9.55B | -1.86% | 7,348,426 | 11.24B |
| 103 | PRAX | Praxis Precision Medicines, Inc. | 9.49B | -0.51% | 414,269 | 7.46M |
| 104 | BTSG | BrightSpring Health Services, Inc. | 9.45B | -3.58% | 1,744,270 | 12.91B |
| 105 | AXSM | Axsome Therapeutics, Inc. | 9.36B | -3.03% | 717,316 | 638.50M |
| 106 | TECH | Bio-Techne Corporation | 9.34B | -1.50% | 1,992,252 | 1.22B |
| 107 | MASI | Masimo Corporation | 9.31B | -0.01% | 673,918 | 1.53B |
| 108 | ABVX | ABIVAX Société Anonyme | 9.12B | -3.09% | 753,005 | 5.37M |
| 109 | HSIC | Henry Schein, Inc. | 9.05B | -0.39% | 1,126,027 | 13.18B |
| 110 | CRL | Charles River Laboratories International, Inc. | 9.03B | -1.32% | 444,887 | 4.02B |
| 111 | ICLR | ICON Public Limited Company | 8.80B | -1.66% | 1,023,870 | 8.10B |
| 112 | PCVX | Vaxcyte, Inc. | 8.71B | -2.32% | 1,014,539 | - |
| 113 | NUVL | Nuvalent, Inc. | 8.42B | -1.03% | 787,024 | - |
| 114 | IBRX | ImmunityBio, Inc. | 8.37B | -1.22% | 13,169,735 | 113.29M |
| 115 | QGEN | Qiagen N.V. | 8.29B | -2.29% | 1,382,827 | 2.09B |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 8.25B | 0.77% | 228,427 | 2.58B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.10B | -1.67% | 1,542,619 | 1.40B |
| 118 | CYTK | Cytokinetics, Incorporated | 8.10B | -0.51% | 1,174,733 | 88.04M |
| 119 | ATR | AptarGroup, Inc. | 8.08B | -3.23% | 310,220 | 3.78B |
| 120 | KRYS | Krystal Biotech, Inc. | 8.03B | -1.39% | 160,920 | 389.13M |
| 121 | MOH | Molina Healthcare, Inc. | 7.87B | 0.59% | 1,375,104 | 43.56B |
| 122 | RGEN | Repligen Corporation | 7.48B | 0.54% | 1,105,711 | 738.26M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 1.31% | 502,293 | 39.21M |
| 124 | GKOS | Glaukos Corporation | 7.14B | -1.96% | 496,740 | 507.44M |
| 125 | HQY | HealthEquity, Inc. | 7.12B | -2.35% | 1,035,944 | 1.31B |
| 126 | ERAS | Erasca, Inc. | 6.97B | 3.22% | 8,969,452 | - |
| 127 | HIMS | Hims & Hers Health, Inc. | 6.78B | -4.03% | 59,041,872 | 2.35B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.76B | 0.40% | 494,871 | 46.02M |
| 129 | GRFS | Grifols, S.A. | 6.75B | -0.94% | 616,867 | 8.83B |
| 130 | ACLX | Arcellx, Inc. | 6.75B | -0.02% | 723,768 | 22.29M |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.71B | -0.07% | 515,552 | - |
| 132 | BLTE | Belite Bio, Inc | 6.50B | -0.12% | 90,352 | - |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.15B | -2.89% | 1,354,764 | - |
| 134 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 2,320,589 | 15.00M |
| 135 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | 0.23% | 6,216,452 | - |
| 136 | BRKR | Bruker Corporation | 6.10B | -2.46% | 1,880,258 | 3.44B |
| 137 | CELC | Celcuity Inc. | 6.09B | 4.98% | 751,411 | - |
| 138 | CGON | CG Oncology, Inc. | 6.07B | 2.05% | 805,997 | 4.04M |
| 139 | COGT | Cogent Biosciences, Inc. | 5.92B | -0.73% | 1,902,918 | - |
| 140 | CAI | Caris Life Sciences, Inc. | 5.89B | -1.93% | 2,056,567 | 812.03M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.85B | -2.34% | 724,194 | 1.73B |
| 142 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.80B | -3.19% | 507,151 | 189.76M |
| 143 | AVTR | Avantor, Inc. | 5.77B | 0.35% | 9,641,697 | 6.55B |
| 144 | IMVT | Immunovant, Inc. | 5.76B | -0.88% | 1,154,647 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 5.72B | -4.30% | 398,806 | 5.10B |
| 146 | PACS | PACS Group, Inc. | 5.64B | -0.28% | 1,142,901 | 5.29B |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 5.63B | -2.49% | 635,322 | 521.31M |
| 148 | ALKS | Alkermes plc | 5.57B | -2.07% | 1,259,425 | 1.48B |
| 149 | SRRK | Scholar Rock Holding Corporation | 5.53B | 0.63% | 1,342,157 | - |
| 150 | TFX | Teleflex Incorporated | 5.52B | -5.46% | 733,618 | 1.99B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.38B | -1.21% | 666,643 | 7.50M |
| 152 | TGTX | TG Therapeutics, Inc. | 5.36B | -1.84% | 2,078,802 | 616.29M |
| 153 | CRSP | CRISPR Therapeutics AG | 5.35B | -3.73% | 2,248,735 | 3.51M |
| 154 | LNTH | Lantheus Holdings, Inc. | 5.30B | -2.86% | 455,223 | 1.54B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 4,067,937 | 1.00B |
| 156 | CHE | Chemed Corporation | 5.01B | -3.11% | 340,650 | 2.53B |
| 157 | WAY | Waystar Holding Corp. | 4.96B | -3.14% | 2,120,977 | 1.10B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | -1.93% | 441,039 | 2.04M |
| 159 | OSCR | Oscar Health, Inc. | 4.81B | -1.64% | 7,878,909 | 11.70B |
| 160 | CORT | Corcept Therapeutics Incorporated | 4.80B | -2.68% | 961,424 | 761.41M |
| 161 | LEGN | Legend Biotech Corporation | 4.66B | 0.60% | 3,871,417 | 1.03B |
| 162 | SHC | Sotera Health Company | 4.55B | -1.84% | 1,963,489 | 1.16B |
| 163 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 2,587,417 | 634.21M |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.52B | -2.20% | 127,704 | 268.09M |
| 165 | RDNT | RadNet, Inc. | 4.50B | -0.59% | 627,759 | 2.04B |
| 166 | DOCS | Doximity, Inc. | 4.46B | -0.98% | 3,365,235 | 637.78M |
| 167 | NVST | Envista Holdings Corporation | 4.43B | -2.33% | 2,413,986 | 2.72B |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.40B | - | 4,750,434 | 3.95B |
| 169 | OPCH | Option Care Health, Inc. | 4.40B | -2.50% | 1,145,493 | 5.65B |
| 170 | STVN | Stevanato Group S.p.A. | 4.19B | -3.22% | 322,015 | 1.39B |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 4.15B | -1.81% | 1,082,530 | 3.02B |
| 172 | BLLN | BillionToOne, Inc. | 4.09B | 2.33% | 616,994 | 305.11M |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -3.35% | 893,067 | 7.70M |
| 174 | MMSI | Merit Medical Systems, Inc. | 4.05B | -2.75% | 472,174 | 1.52B |
| 175 | TNGX | Tango Therapeutics, Inc. | 3.96B | 5.23% | 3,033,561 | 62.38M |
| 176 | VKTX | Viking Therapeutics, Inc. | 3.92B | -4.87% | 3,307,522 | - |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.84B | -4.83% | 494,383 | 747.14M |
| 178 | TWST | Twist Bioscience Corporation | 3.84B | 1.18% | 1,658,097 | 391.56M |
| 179 | TMDX | TransMedics Group, Inc. | 3.76B | -3.73% | 828,824 | 605.49M |
| 180 | NAMS | NewAmsterdam Pharma Company N.V. | 3.73B | -3.96% | 942,422 | 22.50M |
| 181 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -1.31% | 991,559 | 1.07B |
| 182 | MMED | MiniMed Group, Inc. | 3.71B | -4.42% | 850,065 | 2.99B |
| 183 | TVTX | Travere Therapeutics, Inc. | 3.58B | -3.75% | 1,917,418 | 490.73M |
| 184 | LIVN | LivaNova PLC | 3.53B | -1.94% | 1,021,013 | 1.39B |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.52B | -4.66% | 170,178 | 803.79M |
| 186 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | -4.47% | 711,142 | - |
| 187 | HNGE | Hinge Health, Inc. | 3.45B | 1.43% | 996,530 | 587.86M |
| 188 | ORKA | Oruka Therapeutics, Inc. | 3.42B | 0.19% | 733,516 | - |
| 189 | GPCR | Structure Therapeutics Inc. | 3.32B | -2.88% | 1,025,499 | - |
| 190 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.25B | -0.02% | 1,081,466 | 677.56M |
| 191 | ICUI | ICU Medical, Inc. | 3.20B | -1.86% | 354,437 | 2.23B |
| 192 | LQDA | Liquidia Corporation | 3.19B | -3.74% | 1,161,615 | 158.32M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.19B | -2.00% | 1,025,702 | - |
| 194 | ALMS | Alumis Inc. | 3.18B | 1.09% | 1,695,635 | 24.05M |
| 195 | DYN | Dyne Therapeutics, Inc. | 3.17B | -4.05% | 2,358,693 | - |
| 196 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.13B | -1.65% | 835,397 | 588.99M |
| 197 | BKD | Brookdale Senior Living Inc. | 3.12B | -3.10% | 2,642,214 | 3.05B |
| 198 | KLRA | Kailera Therapeutics, Inc. | 3.12B | 2.48% | 843,037 | - |
| 199 | WRBY | Warby Parker Inc. | 3.08B | -2.90% | 2,584,108 | 871.91M |
| 200 | RCUS | Arcus Biosciences, Inc. | 3.07B | 7.83% | 3,647,920 | 247.00M |
| 201 | BEAM | Beam Therapeutics Inc. | 3.05B | -1.60% | 1,747,088 | 139.74M |
| 202 | RLAY | Relay Therapeutics, Inc. | 3.00B | 2.44% | 2,526,902 | 15.36M |
| 203 | PRVA | Privia Health Group, Inc. | 2.96B | -1.99% | 534,042 | 2.12B |
| 204 | TXG | 10x Genomics, Inc. | 2.93B | -6.59% | 4,004,407 | 642.82M |
| 205 | ITGR | Integer Holdings Corporation | 2.92B | -4.14% | 678,059 | 1.85B |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 2.90B | -4.37% | 989,695 | 376.07M |
| 207 | VERA | Vera Therapeutics, Inc. | 2.87B | -3.73% | 686,547 | - |
| 208 | CON | Concentra Group Holdings Parent, Inc. | 2.86B | -2.62% | 391,968 | 2.16B |
| 209 | KOD | Kodiak Sciences Inc. | 2.85B | -0.65% | 560,230 | - |
| 210 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | -4.16% | 502,164 | 718.95M |
| 211 | NKTR | Nektar Therapeutics | 2.82B | -2.18% | 1,602,482 | 55.23M |
| 212 | HAE | Haemonetics Corporation | 2.80B | -1.57% | 589,340 | 1.32B |
| 213 | IDYA | IDEAYA Biosciences, Inc. | 2.80B | -5.27% | 1,391,864 | 218.71M |
| 214 | ZLAB | Zai Lab Limited | 2.75B | -3.21% | 1,424,253 | 460.16M |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -2.21% | 717,065 | 451.36M |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.74B | -1.12% | 782,034 | - |
| 217 | MANE | Veradermics, Incorporated | 2.74B | -0.84% | 161,814 | - |
| 218 | HTFL | HeartFlow, Inc. | 2.73B | 1.50% | 1,834,203 | 176.03M |
| 219 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.04% | 1,804,265 | 190.41M |
| 220 | PBH | Prestige Consumer Healthcare Inc. | 2.72B | -1.98% | 278,480 | 1.10B |
| 221 | IMNM | Immunome, Inc. | 2.70B | -1.65% | 408,734 | 6.94M |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.69B | -0.38% | 797,805 | 1.55M |
| 223 | VCYT | Veracyte, Inc. | 2.66B | 0.18% | 659,974 | 517.15M |
| 224 | LFST | LifeStance Health Group, Inc. | 2.65B | -1.88% | 1,160,959 | 1.42B |
| 225 | IRON | Disc Medicine, Inc. | 2.64B | -3.26% | 275,529 | - |
| 226 | HCM | HUTCHMED (China) Limited | 2.56B | -4.98% | 23,406 | 548.51M |
| 227 | LMAT | LeMaitre Vascular, Inc. | 2.56B | -2.70% | 151,350 | 249.60M |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.53B | -1.44% | 1,709,168 | 3.31B |
| 229 | NHC | National HealthCare Corporation | 2.51B | -3.58% | 145,631 | 1.52B |
| 230 | ADMA | ADMA Biologics, Inc. | 2.50B | -0.92% | 5,310,267 | 510.17M |
| 231 | XRAY | DENTSPLY SIRONA Inc. | 2.46B | -3.75% | 3,132,293 | 3.68B |
| 232 | AAPG | Ascentage Pharma Group International | 2.42B | -2.69% | 4,723 | 82.08M |
| 233 | DFTX | Definium Therapeutics, Inc. | 2.38B | 2.85% | 2,634,049 | - |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | -4.29% | 1,062,554 | - |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -3.83% | 1,387,142 | 673.00M |
| 236 | OGN | Organon & Co. | 2.30B | -4.54% | 5,599,722 | 6.22B |
| 237 | GRDN | Guardian Pharmacy Services, Inc. | 2.28B | -3.54% | 283,680 | 1.45B |
| 238 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.05% | 2,117,966 | 158.18M |
| 239 | PAHC | Phibro Animal Health Corporation | 2.19B | -4.28% | 200,850 | 1.46B |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | -2.54% | 1,531,103 | 276.98M |
| 241 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | -3.45% | 3,092,258 | 2.20B |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | -6.64% | 5,079,141 | 874.84M |
| 243 | BHC | Bausch Health Companies Inc. | 2.14B | -3.05% | 1,502,337 | 10.27B |
| 244 | MESO | Mesoblast Limited | 2.14B | -2.59% | 164,580 | 65.38M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.11B | -2.33% | 428,948 | 184.42M |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -0.88% | 837,650 | 283.06M |
| 247 | GRAL | GRAIL, Inc. | 2.09B | -0.29% | 531,982 | 147.17M |
| 248 | ZYME | Zymeworks Inc. | 2.08B | 1.51% | 490,705 | 105.97M |
| 249 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | -1.89% | 1,192,859 | 172.35M |
| 250 | NEOG | Neogen Corporation | 2.05B | -2.18% | 2,547,021 | 870.56M |
| 251 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -5.06% | 2,309,462 | - |
| 252 | CAPR | Capricor Therapeutics, Inc. | 2.04B | 3.30% | 803,285 | 11.13M |
| 253 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 823,420 | 5.45B |
| 254 | OCUL | Ocular Therapeutix, Inc. | 2.03B | -2.10% | 3,515,896 | 51.95M |
| 255 | WGS | GeneDx Holdings Corp. | 1.99B | -2.31% | 926,686 | 427.54M |
| 256 | TYRA | Tyra Biosciences, Inc. | 1.98B | 6.75% | 1,266,869 | - |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | 0.11% | 824,893 | -665.00K |
| 258 | GLPG | Galapagos NV | 1.91B | -1.20% | 180,209 | 1.31B |
| 259 | PHVS | Pharvaris N.V. | 1.91B | 0.62% | 83,185 | - |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.88B | -4.29% | 428,846 | 211.08M |
| 261 | SION | Sionna Therapeutics, Inc. | 1.88B | -1.99% | 366,738 | - |
| 262 | RXRX | Recursion Pharmaceuticals, Inc. | 1.88B | -3.52% | 11,885,366 | 74.68M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 1.87B | 1.02% | 233,148 | - |
| 264 | SGRY | Surgery Partners, Inc. | 1.87B | 1.89% | 1,034,451 | 3.31B |
| 265 | AXGN | Axogen, Inc. | 1.86B | -3.60% | 985,736 | 225.21M |
| 266 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 8.84% | 3,943,226 | 868.45M |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.86B | -1.34% | 634,608 | 1.91B |
| 268 | ANIP | ANI Pharmaceuticals, Inc. | 1.82B | -2.19% | 309,831 | 883.37M |
| 269 | NTLA | Intellia Therapeutics, Inc. | 1.81B | 0.66% | 4,309,902 | 67.67M |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -3.72% | 2,050,040 | 9.77M |
| 271 | NUVB | Nuvation Bio Inc. | 1.78B | -0.20% | 3,590,388 | 62.90M |
| 272 | ATAI | AtaiBeckley Inc. | 1.78B | -0.61% | 14,758,097 | 4.09M |
| 273 | AORT | Artivion, Inc. | 1.77B | -5.77% | 421,418 | 441.33M |
| 274 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -0.51% | 428,226 | - |
| 275 | INVA | Innoviva, Inc. | 1.75B | -1.30% | 536,618 | 411.33M |
| 276 | VIR | Vir Biotechnology, Inc. | 1.75B | -2.34% | 1,409,474 | 68.56M |
| 277 | VCEL | Vericel Corporation | 1.71B | -5.98% | 659,763 | 276.26M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -3.52% | 831,151 | 71.78M |
| 279 | AHG | Akso Health Group | 1.69B | - | 179,857 | 14.84M |
| 280 | GLUE | Monte Rosa Therapeutics, Inc. | 1.67B | 5.45% | 876,817 | 123.67M |
| 281 | OMCL | Omnicell, Inc. | 1.67B | -2.78% | 344,558 | 1.18B |
| 282 | ADUS | Addus HomeCare Corporation | 1.66B | -2.00% | 263,399 | 1.42B |
| 283 | AHCO | AdaptHealth Corp. | 1.65B | -4.10% | 1,468,139 | 3.24B |
| 284 | PLSE | Pulse Biosciences, Inc. | 1.63B | 1.05% | 200,391 | 350.00K |
| 285 | OCS | Oculis Holding AG | 1.62B | -4.30% | 1,083,722 | 1.51M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.62B | 1.48% | 189,547 | - |
| 287 | GENB | Generate Biomedicines, Inc. | 1.61B | 4.54% | 620,329 | 31.89M |
| 288 | PRGO | Perrigo Company plc | 1.61B | -2.57% | 2,106,527 | 4.25B |
| 289 | ASTH | Astrana Health, Inc. | 1.61B | 3.50% | 678,765 | 3.18B |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.61B | -0.69% | 641,988 | 336.39M |
| 291 | ATEC | Alphatec Holdings, Inc. | 1.59B | -9.26% | 2,996,366 | 764.16M |
| 292 | ALMR | Alamar Biosciences, Inc. | 1.58B | 5.59% | 457,305 | 74.21M |
| 293 | MBX | MBX Biosciences, Inc. | 1.58B | -1.60% | 436,267 | - |
| 294 | AGIO | Agios Pharmaceuticals, Inc. | 1.54B | -2.88% | 1,616,613 | 54.03M |
| 295 | BHVN | Biohaven Ltd. | 1.53B | -5.82% | 2,287,163 | - |
| 296 | UFPT | UFP Technologies, Inc. | 1.53B | -1.19% | 185,244 | 602.80M |
| 297 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -2.12% | 10,956,528 | 263.50M |
| 298 | BCAX | Bicara Therapeutics Inc. | 1.51B | -1.53% | 613,697 | - |
| 299 | NBTX | Nanobiotix S.A. | 1.50B | -3.54% | 88,941 | 38.27M |
| 300 | IMTX | Immatics N.V. | 1.50B | -0.62% | 282,235 | 56.67M |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.50B | -8.67% | 1,166,677 | 911.98M |
| 302 | IMCR | Immunocore Holdings plc | 1.50B | -6.17% | 434,222 | 400.02M |
| 303 | ANAB | AnaptysBio, Inc. | 1.49B | 1.71% | 643,270 | 234.60M |
| 304 | HROW | Harrow, Inc. | 1.47B | -2.59% | 527,225 | 272.30M |
| 305 | ARDX | Ardelyx, Inc. | 1.46B | -5.40% | 3,963,310 | 407.32M |
| 306 | VRDN | Viridian Therapeutics, Inc. | 1.46B | -2.72% | 2,076,793 | 70.85M |
| 307 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 0.30% | 751,195 | - |
| 308 | CRVS | Corvus Pharmaceuticals, Inc. | 1.44B | 10.30% | 1,486,677 | - |
| 309 | NVCR | NovoCure Limited | 1.42B | -3.47% | 884,722 | 655.35M |
| 310 | WVE | Wave Life Sciences Ltd. | 1.41B | -3.17% | 4,337,101 | 42.73M |
| 311 | PGNY | Progyny, Inc. | 1.41B | -3.33% | 1,301,596 | 1.29B |
| 312 | PGEN | Precigen, Inc. | 1.41B | -3.16% | 1,653,129 | 9.68M |
| 313 | PRCT | PROCEPT BioRobotics Corporation | 1.40B | -3.77% | 779,542 | 308.05M |
| 314 | AVAH | Aveanna Healthcare Holdings Inc. | 1.39B | -6.70% | 1,629,924 | 2.43B |
| 315 | ARDT | Ardent Health, Inc. | 1.39B | -4.13% | 430,693 | 6.32B |
| 316 | BFLY | Butterfly Network, Inc. | 1.39B | -0.73% | 6,798,429 | 97.61M |
| 317 | ATRC | AtriCure, Inc. | 1.39B | -4.93% | 893,027 | 534.53M |
| 318 | NVAX | Novavax, Inc. | 1.38B | -2.08% | 3,959,711 | 1.12B |
| 319 | TNDM | Tandem Diabetes Care, Inc. | 1.37B | -5.70% | 1,340,693 | 1.01B |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.37B | -1.31% | 630,334 | - |
| 321 | ENOV | Enovis Corporation | 1.37B | -9.67% | 1,376,000 | 2.25B |
| 322 | HCSG | Healthcare Services Group, Inc. | 1.36B | 0.16% | 1,012,475 | 1.84B |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.35B | -0.49% | 258,051 | 83.72M |
| 324 | SVRA | Savara Inc. | 1.34B | -5.88% | 1,226,139 | - |
| 325 | GHRS | GH Research PLC | 1.28B | -3.95% | 454,021 | - |
| 326 | MAZE | Maze Therapeutics, Inc. | 1.28B | -4.28% | 716,552 | 2.50M |
| 327 | CLOV | Clover Health Investments, Corp. | 1.25B | 7.17% | 11,809,604 | 1.92B |
| 328 | CMPS | COMPASS Pathways plc | 1.25B | -2.22% | 8,629,449 | - |
| 329 | MLTX | MoonLake Immunotherapeutics | 1.24B | -3.75% | 729,751 | - |
| 330 | STAA | STAAR Surgical Company | 1.23B | -2.39% | 462,063 | 239.44M |
| 331 | INBX | Inhibrx Biosciences, Inc. | 1.23B | 2.05% | 704,769 | 1.30M |
| 332 | URGN | UroGen Pharma Ltd. | 1.22B | 0.44% | 1,115,437 | 109.79M |
| 333 | MPLT | MapLight Therapeutics, Inc. | 1.22B | -2.54% | 425,516 | - |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.22B | -2.20% | 426,620 | 10.00M |
| 335 | AZTA | Azenta, Inc. | 1.21B | -0.45% | 1,222,016 | 595.03M |
| 336 | ABCL | AbCellera Biologics Inc. | 1.21B | 2.05% | 3,867,207 | 75.13M |
| 337 | PHAR | Pharming Group N.V. | 1.21B | -2.50% | 4,396 | 376.13M |
| 338 | DBVT | DBV Technologies S.A. | 1.19B | -4.90% | 386,427 | 5.64M |
| 339 | NNNN | Anbio Biotechnology | 1.19B | 0.24% | 17,486 | 8.65M |
| 340 | EVO | Evotec SE | 1.18B | 2.54% | 164,769 | 925.65M |
| 341 | EYPT | EyePoint, Inc. | 1.18B | -6.37% | 1,534,457 | 31.37M |
| 342 | SEPN | Septerna, Inc. | 1.16B | -3.95% | 363,362 | 45.95M |
| 343 | CNMD | CONMED Corporation | 1.16B | -3.35% | 321,683 | 1.37B |
| 344 | AVNS | Avanos Medical, Inc. | 1.15B | - | 1,401,129 | 701.20M |
| 345 | USPH | U.S. Physical Therapy, Inc. | 1.14B | -0.25% | 157,156 | 773.34M |
| 346 | IRMD | IRADIMED CORPORATION | 1.14B | -4.04% | 121,033 | 83.81M |
| 347 | JBIO | Jade Biosciences, Inc. | 1.13B | -2.09% | 793,493 | - |
| 348 | AKTS | Aktis Oncology, Inc. | 1.13B | -1.58% | 294,876 | 6.50M |
| 349 | IVA | Inventiva S.A. | 1.12B | -3.40% | 164,862 | 7.94M |
| 350 | QURE | uniQure N.V. | 1.10B | -3.27% | 1,128,304 | 16.10M |
| 351 | ALVO | Alvotech | 1.10B | -3.04% | 650,687 | 588.90M |
| 352 | TDOC | Teladoc Health, Inc. | 1.08B | -1.64% | 6,186,755 | 2.53B |
| 353 | BLFS | BioLife Solutions, Inc. | 1.08B | 0.81% | 672,776 | 96.21M |
| 354 | COLL | Collegium Pharmaceutical, Inc. | 1.08B | -3.03% | 253,772 | 780.57M |
| 355 | ORIC | ORIC Pharmaceuticals, Inc. | 1.07B | -2.39% | 1,279,166 | - |
| 356 | CDNA | CareDx, Inc. | 1.06B | -2.63% | 488,523 | 379.81M |
| 357 | CRON | Cronos Group Inc. | 1.04B | -1.09% | 1,463,521 | 146.59M |
| 358 | NEO | NeoGenomics, Inc. | 1.04B | -3.28% | 2,023,087 | 727.33M |
| 359 | INNV | InnovAge Holding Corp. | 1.03B | -4.53% | 260,341 | 915.37M |
| 360 | CTMX | CytomX Therapeutics, Inc. | 1.03B | -2.66% | 3,915,473 | 76.20M |
| 361 | PHAT | Phathom Pharmaceuticals, Inc. | 1.02B | -4.38% | 1,423,157 | 175.11M |
| 362 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -5.76% | 2,057,750 | 291.85M |
| 363 | SANA | Sana Biotechnology, Inc. | 1.02B | -3.14% | 4,052,215 | - |
| 364 | EVMN | Evommune, Inc. | 1.01B | 0.36% | 157,869 | 13.00M |
| 365 | PNTG | The Pennant Group, Inc. | 1.01B | -2.50% | 245,663 | 947.71M |
| 366 | PCRX | Pacira BioSciences, Inc. | 997.67M | -1.04% | 315,737 | 726.41M |
| 367 | KALV | KalVista Pharmaceuticals, Inc. | 995.25M | -6.90% | 1,298,985 | 73.62M |
| 368 | ANNX | Annexon, Inc. | 994.94M | -3.58% | 1,695,133 | - |
| 369 | FTRE | Fortrea Holdings Inc. | 964.92M | -1.15% | 1,084,834 | 2.72B |
| 370 | GERN | Geron Corporation | 961.35M | -3.85% | 15,757,209 | 183.88M |
| 371 | OMER | Omeros Corporation | 954.67M | -1.56% | 828,956 | - |
| 372 | SDGR | Schrödinger, Inc. | 950.87M | 0.63% | 1,221,469 | 255.87M |
| 373 | CERT | Certara, Inc. | 950.62M | 0.16% | 2,259,274 | 418.84M |
| 374 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.01M | 1.94% | 2,513,653 | 185.74M |
| 375 | AMPH | Amphastar Pharmaceuticals, Inc. | 944.59M | -7.46% | 684,150 | 719.89M |
| 376 | CMPX | Compass Therapeutics, Inc. | 943.66M | -3.32% | 2,735,308 | 850.00K |
| 377 | MGTX | MeiraGTx Holdings plc | 941.31M | -3.42% | 1,262,073 | 81.39M |
| 378 | JANX | Janux Therapeutics, Inc. | 940.46M | -2.58% | 1,965,809 | 10.00M |
| 379 | OPK | OPKO Health, Inc. | 926.06M | - | 1,499,758 | 606.88M |
| 380 | XNCR | Xencor, Inc. | 924.80M | -1.48% | 395,678 | 125.58M |
| 381 | SSII | SS Innovations International, Inc. | 919.72M | -5.15% | 66,660 | 42.48M |
| 382 | INMD | InMode Ltd. | 919.02M | -0.45% | 361,132 | 370.50M |
| 383 | LBRX | LB Pharmaceuticals Inc | 911.29M | 0.35% | 333,487 | - |
| 384 | SLS | SELLAS Life Sciences Group, Inc. | 903.30M | 0.80% | 4,397,022 | - |
| 385 | ANRO | Alto Neuroscience, Inc. | 897.00M | -6.37% | 318,541 | - |
| 386 | LMRI | Lumexa Imaging Holdings, Inc. | 895.74M | -3.42% | 1,373,283 | 1.02B |
| 387 | ABUS | Arbutus Biopharma Corporation | 872.44M | -3.70% | 914,675 | 14.08M |
| 388 | BIOA | BioAge Labs, Inc. | 870.29M | 4.31% | 694,629 | 9.00M |
| 389 | TALK | Talkspace, Inc. | 867.12M | 0.19% | 1,237,101 | 228.87M |
| 390 | CGEM | Cullinan Therapeutics, Inc. | 860.68M | -2.07% | 673,807 | - |
| 391 | TBPH | Theravance Biopharma, Inc. | 855.81M | -0.60% | 478,892 | 107.46M |
| 392 | DRUG | Bright Minds Biosciences Inc. | 844.51M | -3.71% | 235,159 | - |
| 393 | OMDA | Omada Health, Inc. | 842.04M | 1.78% | 724,389 | 260.21M |
| 394 | KURA | Kura Oncology, Inc. | 840.58M | -3.17% | 1,533,813 | 67.48M |
| 395 | MNKD | MannKind Corporation | 833.75M | -7.53% | 5,216,786 | 348.97M |
| 396 | SGP | SpyGlass Pharma, Inc. | 822.13M | 0.31% | 30,339 | - |
| 397 | VOR | Vor Biopharma Inc. | 822.00M | -3.44% | 1,146,696 | - |
| 398 | IART | Integra LifeSciences Holdings Corporation | 819.90M | -5.73% | 546,788 | 1.64B |
| 399 | QDEL | QuidelOrtho Corporation | 819.70M | -6.59% | 2,374,385 | 2.73B |
| 400 | DSGN | Design Therapeutics, Inc. | 819.62M | 0.99% | 453,772 | - |
| 401 | CBIO | Crescent Biopharma, Inc. | 816.07M | 13.28% | 544,040 | 10.84M |
| 402 | AMN | AMN Healthcare Services, Inc. | 805.21M | 1.81% | 683,190 | 2.73B |
| 403 | FBRX | Forte Biosciences, Inc. | 803.86M | -4.62% | 202,068 | - |
| 404 | SLDB | Solid Biosciences Inc. | 802.90M | -3.89% | 991,833 | - |
| 405 | BVS | Bioventus Inc. | 801.61M | -6.23% | 482,696 | 568.09M |
| 406 | TLRY | Tilray Brands, Inc. | 800.81M | -3.64% | 4,284,180 | 858.28M |
| 407 | ALLO | Allogene Therapeutics, Inc. | 798.03M | -4.13% | 8,823,016 | 22.00K |
| 408 | GDRX | GoodRx Holdings, Inc. | 791.35M | -2.53% | 923,154 | 796.85M |
| 409 | CBLL | CeriBell, Inc. | 788.21M | -0.90% | 240,827 | 89.06M |
| 410 | SPRY | ARS Pharmaceuticals, Inc. | 778.49M | -4.16% | 1,481,718 | 84.28M |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 775.34M | -0.54% | 1,402,013 | 49.80M |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 757.11M | 2.16% | 908,450 | - |
| 413 | RLMD | Relmada Therapeutics, Inc. | 748.90M | -3.12% | 1,978,572 | - |
| 414 | CSTL | Castle Biosciences, Inc. | 744.67M | -2.31% | 492,892 | 344.23M |
| 415 | NUTX | Nutex Health Inc. | 739.90M | -2.84% | 75,423 | 875.26M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 718.64M | -0.88% | 68,833 | 116.59M |
| 417 | EHAB | Enhabit, Inc. | 695.92M | - | 594,386 | 1.06B |
| 418 | DRTS | Alpha Tau Medical Ltd. | 695.28M | -2.59% | 158,568 | - |
| 419 | TENX | Tenax Therapeutics, Inc. | 688.11M | -2.98% | 274,054 | - |
| 420 | ARVN | Arvinas, Inc. | 679.27M | -1.76% | 679,284 | 262.60M |
| 421 | PRME | Prime Medicine, Inc. | 674.67M | -2.06% | 2,129,099 | 4.63M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 663.65M | -7.92% | 1,912,283 | 296.15M |
| 423 | PSNL | Personalis, Inc. | 653.19M | -1.58% | 2,647,951 | 69.65M |
| 424 | BWAY | BrainsWay Ltd. | 648.57M | -2.23% | 78,060 | 52.23M |
| 425 | ETON | Eton Pharmaceuticals, Inc. | 642.28M | -6.88% | 404,241 | 79.95M |
| 426 | ANL | Adlai Nortye Ltd. | 638.40M | -3.86% | 385,434 | 5.00M |
| 427 | EIKN | Eikon Therapeutics, Inc. | 635.59M | 1.65% | 127,792 | - |
| 428 | PROK | ProKidney Corp. | 631.00M | -0.48% | 529,118 | 893.00K |
| 429 | HSTM | HealthStream, Inc. | 627.64M | 0.19% | 147,065 | 304.06M |
| 430 | SIBN | SI-BONE, Inc. | 610.36M | -3.49% | 774,273 | 200.93M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 610.01M | -3.62% | 764,392 | 106.47M |
| 432 | OCGN | Ocugen, Inc. | 598.08M | -4.32% | 4,009,583 | 4.41M |
| 433 | ABSI | Absci Corporation | 596.78M | -1.27% | 6,080,148 | 2.80M |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 596.50M | -0.62% | 248,438 | 294.28M |
| 435 | CTKB | Cytek Biosciences, Inc. | 595.19M | 1.31% | 707,857 | 201.49M |
| 436 | TRAX | First Tracks Biotherapeutics, Inc. | 590.73M | -8.60% | 1,031,451 | - |
| 437 | KYTX | Kyverna Therapeutics, Inc. | 587.75M | -13.69% | 1,765,349 | - |
| 438 | STTK | Shattuck Labs, Inc. | 586.51M | -1.52% | 386,325 | 1.00M |
| 439 | CRMD | CorMedix Inc. | 583.39M | -2.64% | 798,471 | 311.71M |
| 440 | ACRS | Aclaris Therapeutics, Inc. | 579.61M | -1.88% | 1,711,348 | 7.83M |
| 441 | PRTA | Prothena Corporation plc | 574.40M | -1.11% | 451,035 | 9.68M |
| 442 | AVR | Anteris Technologies Global Corp. | 571.63M | -3.72% | 440,368 | 1.91M |
| 443 | ENGN | enGene Therapeutics Inc. | 570.08M | -0.23% | 173,553 | - |
| 444 | STRO | Sutro Biopharma, Inc. | 569.08M | -0.67% | 192,587 | 102.48M |
| 445 | PHR | Phreesia, Inc. | 568.74M | -0.74% | 1,278,273 | 480.59M |
| 446 | TCMD | Tactile Systems Technology, Inc. | 564.21M | -2.82% | 141,693 | 329.52M |
| 447 | LYEL | Lyell Immunopharma, Inc. | 557.67M | -3.92% | 76,433 | 36.00K |
| 448 | NPCE | NeuroPace, Inc. | 551.13M | -0.97% | 172,477 | 99.99M |
| 449 | BBNX | Beta Bionics, Inc. | 546.77M | -4.96% | 991,776 | 110.24M |
| 450 | ARMP | Armata Pharmaceuticals, Inc. | 542.17M | 18.40% | 141,666 | 4.90M |
| 451 | EMBC | Embecta Corp. | 540.68M | -4.90% | 641,833 | 1.08B |
| 452 | AGMB | AgomAb Therapeutics NV | 533.67M | 1.48% | 97,041 | - |
| 453 | VSTM | Verastem, Inc. | 531.45M | -7.21% | 1,735,304 | 30.91M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 529.68M | 2.36% | 1,350,892 | 44.55M |
| 455 | VALN | Valneva SE | 529.55M | -1.82% | 72,607 | 205.07M |
| 456 | CATX | Perspective Therapeutics, Inc. | 528.65M | 1.98% | 1,142,748 | 884.00K |
| 457 | ADCT | ADC Therapeutics SA | 522.75M | -3.29% | 1,381,902 | 81.36M |
| 458 | PACB | Pacific Biosciences of California, Inc. | 522.46M | -0.57% | 8,036,347 | 160.01M |
| 459 | TECX | Tectonic Therapeutic, Inc. | 518.99M | -3.89% | 451,460 | - |
| 460 | IMMX | Immix Biopharma, Inc. | 513.16M | -4.06% | 1,554,432 | - |
| 461 | CADL | Candel Therapeutics, Inc. | 512.73M | -3.05% | 3,513,016 | - |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 463 | UPB | Upstream Bio, Inc. | 503.93M | -7.31% | 526,920 | 2.85M |
| 464 | VREX | Varex Imaging Corporation | 503.03M | 0.25% | 435,687 | 854.40M |
| 465 | ZURA | Zura Bio Limited | 501.92M | -1.49% | 591,078 | - |
| 466 | FULC | Fulcrum Therapeutics, Inc. | 501.50M | -5.16% | 838,961 | 80.00M |
| 467 | FDMT | 4D Molecular Therapeutics, Inc. | 498.26M | -3.08% | 843,247 | 85.21M |
| 468 | ESPR | Esperion Therapeutics, Inc. | 493.08M | -4.95% | 12,393,164 | 403.14M |
| 469 | CTNM | Contineum Therapeutics, Inc. | 490.97M | -2.38% | 92,263 | - |
| 470 | OFIX | Orthofix Medical Inc. | 485.75M | -4.35% | 198,730 | 822.31M |
| 471 | KMDA | Kamada Ltd. | 482.84M | -2.40% | 24,583 | 180.46M |
| 472 | DNA | Ginkgo Bioworks Holdings, Inc. | 477.88M | 2.88% | 1,223,842 | 170.16M |
| 473 | VTVT | vTv Therapeutics Inc. | 477.77M | 1.46% | 69,098 | 17.00K |
| 474 | AURA | Aura Biosciences, Inc. | 477.28M | 5.53% | 383,594 | - |
| 475 | MDXG | MiMedx Group, Inc. | 475.41M | -1.54% | 1,975,024 | 418.63M |
| 476 | LRMR | Larimar Therapeutics, Inc. | 474.75M | -4.99% | 963,071 | - |
| 477 | XOMA | XOMA Royalty Corporation | 471.62M | -1.05% | 101,518 | 52.15M |
| 478 | MYGN | Myriad Genetics, Inc. | 471.27M | -2.92% | 724,957 | 824.50M |
| 479 | TRDA | Entrada Therapeutics, Inc. | 470.52M | -3.61% | 99,231 | 25.42M |
| 480 | RGNX | REGENXBIO Inc. | 470.23M | -3.80% | 638,686 | 170.44M |
| 481 | PALI | Palisade Bio, Inc. | 468.78M | 12.00% | 10,791,773 | - |
| 482 | LXEO | Lexeo Therapeutics, Inc. | 466.01M | -3.68% | 764,099 | - |
| 483 | FLGT | Fulgent Genetics, Inc. | 459.78M | -1.48% | 295,731 | 322.67M |
| 484 | BNTC | Benitec Biopharma Inc. | 451.48M | -5.79% | 87,385 | - |
| 485 | IVVD | Invivyd, Inc. | 449.66M | -5.36% | 1,146,901 | 53.43M |
| 486 | CLYM | Climb Bio, Inc. | 447.59M | 4.46% | 809,837 | - |
| 487 | ANGO | AngioDynamics, Inc. | 446.83M | -0.65% | 332,317 | 313.73M |
| 488 | ALT | Altimmune, Inc. | 443.66M | -4.21% | 3,250,804 | 41.00K |
| 489 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | -3.33% | 397,083 | - |
| 490 | CGC | Canopy Growth Corporation | 435.23M | -5.00% | 11,885,778 | 203.04M |
| 491 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.91M | -2.50% | 192,202 | - |
| 492 | PRTC | PureTech Health plc | 430.07M | -1.69% | 1,324 | 6.39M |
| 493 | ASMB | Assembly Biosciences, Inc. | 428.45M | -3.98% | 183,010 | 72.30M |
| 494 | WEAV | Weave Communications, Inc. | 426.28M | -0.91% | 626,427 | 239.02M |
| 495 | NMRA | Neumora Therapeutics, Inc. | 422.33M | 5.94% | 1,887,375 | - |
| 496 | CYH | Community Health Systems, Inc. | 414.98M | -1.59% | 2,144,865 | 12.29B |
| 497 | SRTA | Strata Critical Medical, Inc. | 414.08M | 5.97% | 1,256,049 | 197.14M |
| 498 | IPSC | Century Therapeutics, Inc. | 413.36M | -1.71% | 778,803 | 109.16M |
| 499 | EBS | Emergent BioSolutions Inc. | 413.16M | -4.19% | 564,843 | 742.90M |
| 500 | NGNE | Neurogene Inc. | 412.72M | -4.47% | 137,094 | 925.00K |